Literature DB >> 25332559

Acute human parvovirus b19 infection: cytologic diagnosis.

Rane Sharada Raju1, Kadgi Nalini Vinayak2, Vishnuprasad Madhusudan Bapat3, Agrawal Preeti Balkisanji4, Puranik Shaila Chandrakant5.   

Abstract

Human parvovirus B19 is highly tropic to human bone marrow and replicates only in erythroid progenitor cells. It is causative agent of transient aplastic crisis in patients with chronic haemolytic anemia. In immunocompromised patients persistent parvovirus B19 infection may develop and it manifests as pure red cell aplasia and chronic anaemia. Bone marrow is characterised morphologically by giant pronormoblast stage with little or no further maturation. We encountered a case of 6 year old HIV positive male child presented with pure red cell aplasia due to parvovirus B19 infection. Bone marrow aspiration cytology revealed giant pronormoblast with prominent intranuclear inclusions led to suspicion of parvovirus B19 infection which was confirmed by DNA PCR. This case is presented to report classical morphological features of parvovirus B19 infection rarely seen on bone marrow examination should warrant the suspicion of human parvovirus B19 infection in the setting of HIV positive patient with repeated transfusions and confirmation should be done by PCR.

Entities:  

Keywords:  HIV; Parvovirus; Pure red cell aplasia

Year:  2013        PMID: 25332559      PMCID: PMC4192177          DOI: 10.1007/s12288-013-0287-7

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  6 in total

1.  Human parvovirus B19 causes cell cycle arrest of human erythroid progenitors via deregulation of the E2F family of transcription factors.

Authors:  Zhihong Wan; Ning Zhi; Susan Wong; Keyvan Keyvanfar; Delong Liu; Nalini Raghavachari; Peter J Munson; Su Su; Daniela Malide; Sachiko Kajigaya; Neal S Young
Journal:  J Clin Invest       Date:  2010-09-20       Impact factor: 14.808

2.  Clinical relevance of parvovirus B19 as a cause of anemia in patients with human immunodeficiency virus infection.

Authors:  J L Abkowitz; K E Brown; R W Wood; N L Kovach; S W Green; N S Young
Journal:  J Infect Dis       Date:  1997-07       Impact factor: 5.226

3.  Erythrocyte P antigen: cellular receptor for B19 parvovirus.

Authors:  K E Brown; S M Anderson; N S Young
Journal:  Science       Date:  1993-10-01       Impact factor: 47.728

Review 4.  Parvoviruses and bone marrow failure.

Authors:  K E Brown; N S Young
Journal:  Stem Cells       Date:  1996-03       Impact factor: 6.277

5.  Parvovirus-like particles in human sera.

Authors:  Y E Cossart; A M Field; B Cant; D Widdows
Journal:  Lancet       Date:  1975-01-11       Impact factor: 79.321

Review 6.  Parvovirus B19 infection and hematopoiesis.

Authors:  K E Brown; N S Young
Journal:  Blood Rev       Date:  1995-09       Impact factor: 8.250

  6 in total
  1 in total

1.  Detection of parvovirus B19 in selected high-risk patient groups & their phylogenetic & selection analysis.

Authors:  Kumaran Vadivel; Ramamurthy Mageshbabu; Sathish Sankar; Amita Jain; Vivekanandan Perumal; Padma Srikanth; Ghosh Asit Ranjan; Aravindan Nair; Eric A F Simoes; Balaji Nandagopal; Gopalan Sridharan
Journal:  Indian J Med Res       Date:  2018-04       Impact factor: 2.375

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.